Submitted by Anonymous (not verified) on 10 September 2025 - 13:21
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 20, Status: Authorised